Uitgangsvraag 3:  Wat is de waarde van hyperthermic intraperitoneal chemotherapy (HIPEC) bij patiënten met een peritoneaal gemetastaseerd maagcarcinoom of een advanced maagcarcinoom?

P

Patiënten met een peritoneaal gemetastaseerd  maagcarcinoom of een advanced maagcarcinoom

I

hyperthermic intraperitoneal chemotherapy (HIPEC)

C

best supportive care, palliatieve chemotherapie, systemische therapie

O

Kwaliteit van leven, overleving

Studies

• (1) meta-analyses, systematische reviews, (2) randomised controlled trials (RCT), controlled clinical trials (CCT) (3) observationele vergelijkende cohort

Periode (vanaf tot):

2004-nu

Databases:

Medline, Embase, Cochrane (CDSR)

Taal:

Eng. Ned.

Reference

In/Ex

Reason for exclusion

1.

Yu, W., A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy. Eur J Surg Oncol, 2006. 32(6): p. 655-60.

Ex

Other study type (narrative review: no systematic search or selection)

2.

Yonemura, Y., et al., Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur J Surg Oncol, 2010. 36(12): p. 1131-8.

Ex

Other study type (narrative review: no systematic search or selection)

3.

Yonemura, Y., et al., Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol, 2010. 2(2): p. 85-97.

Ex

Other study type (narrative review: no systematic search or selection)

4.

Yonemura, Y., et al., Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. Cancer Treatment & Research, 2007. 134: p. 357-73.

Ex

Other study type (narrative review: no systematic search or selection)

5.

Yarema, R.R., et al., Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: results of a single-centre retrospective study. Int J Hyperthermia, 2014. 30(3): p. 159-65.

Ex

Other study type (retrospective matched control study)

6.

Yano M, et al., Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer. J. Surg. Oncol., 2004. 88(1): p. 39-43.

Ex

Other study type (no control group)

7.

Yang, X.-J., et al., Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol, 2011. 18(6): p. 1575-81.

Ex

Included in Coccolini 2014

8.

Ung, L., T.C. Chua, and D.L. Morris, Cure for peritoneal metastases? An evidence-based review. ANZ J Surg, 2013. 83(11): p. 821-6.

Ex

Other study type (narrative review: no systematic search or selection)

9.

Suo, T., H. Mahteme, and X.-Y. Qin, Hyperthermic intraperitoneal chemotherapy for gastric and colorectal cancer in Mainland China. World J Gastroenterol, 2011. 17(8): p. 1071-5.

Ex

Other study type (no control group)

10.

Sun J, et al., Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: A meta-analysis of the randomized controlled trials. BMC Cancer, 2012. 12.

In

SR of RCTs

11.

Sugarbaker, P.H., Adjuvant intraperitoneal chemotherapy for advanced primary gastric cancer. Scandinavian Journal of Surgery: SJS, 2006. 95(4): p. 270-3.

Ex

Other study type (narrative review: no systematic search or selection)

12.

Shi, C., et al., Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer. Oncology, 2011. 80(5-6): p. 289-95.

Ex

Other study type (retrospective controlled cohort study)

13.

Saito, H., et al., Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis. J Surg Oncol, 2011. 104(5): p. 534-7.

Ex

Other study type (retrospective cohort study)

14.

Rudloff, U., et al., Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol, 2014. 110(3): p. 275-84.

In

RCT

15.

Oh, C.A., et al., Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology. J Surg Oncol, 2012. 105(4): p. 393-9.

Ex

Other study type (retrospective cohort study)

16.

Mueller H, Hahn M, and Simsa J, Is it feasible? Hepatogastroenterology, 2008. 55(88): p. 2005-2011.

Ex

Other study type (retrospective cohort study)

17.

Mochiki, E., et al., Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding. Int J Hyperthermia, 2007. 23(6): p. 493-500.

Ex

Other study type (allocation according to patient preference, while RCTs are available)

18.

Mizumoto, A., et al., Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan. Gastroenterology research & practice, 2012. 836425.

Ex

Other study type (no control group)

19.

Miyashiro, I., et al., Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2. Gastric Cancer, 2011. 14(3): p. 212-8.

Ex

Other intervention (more extensive postoperative chemotherapy)

20.

Matharu, G., O. Tucker, and D. Alderson, Systematic review of intraperitoneal chemotherapy for gastric cancer. Br J Surg, 2011. 98(9): p. 1225-35.

Ex

SR of RCTs and other study types; only 1 relevant RCT included

21.

Magge, D., et al., Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis. Ann Surg Oncol, 2014. 21(5): p. 1448-55.

Ex

Other study type (no control group)

22.

Li, Y., et al., An evaluation of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy on patients with peritoneal carcinomatosis: Final results of a phase II prospective and randomized clinical trial. J Clin Oncol, 2011. 29(15 SUPPL. 1).

In

RCT. Abstract only; not included in Coccolini

23.

Li, C., et al., Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination. J Surg Oncol, 2010. 102(5): p. 361-5.

Ex

Other study type (retrospective controlled cohort study)

24.

Lee J.-H, et al., Factors predicting peritoneal recurrence in advanced gastric cancer: Implication for adjuvant intraperitoneal chemotherapy. Gastric Cancer, 2014. 17(3): p. 529-536.

Ex

Other study type (no control group)

25.

Kuramoto, M., et al., Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg, 2009. 250(2): p. 242-6.

Ex

Included in Coccolini 2014

26.

Kober F, Karik M, and Hermann M, Potentially curative strategies in peritoneal metastases. Memo Mag. Euro. Med. Oncol., 2009. 2(1): p. 34-37.

Ex

Other study type (narrative review: no systematic search or selection)

27.

Kim, K.W., et al., Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy. Am J Surg, 2014. 207(1): p. 78-83.

Ex

Other study type (retrospective controlled cohort study)

28.

Kim, J.H., et al., Surgical outcomes and prognostic factors for T4 gastric cancers. Asian journal of surgery / Asian Surgical Association, 2009. 32(4): p. 198-204.

Ex

Outcomes not compared for IPC vs. no IPC

29.

Kerkar, S.P., et al., The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials, 2009. 10: p. 121.

In

Protocol of Rudloff 2014

30.

Kavanagh, M., J.-F. Ouellet, and O. Comite de l'Evolution des Pratiques en, Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy. Bull Cancer, 2006. 93(9): p. 867-74.

Ex

French

31.

Ikeguchi M, Yamamoto O, and Kaibara N, Management protocol for scirrhous gastric cancer. In Vivo, 2004. 18(5): p. 577-580.

Ex

Other comparison

32.

Hultman, B., et al., Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer. Acta Oncol, 2012. 51(1): p. 112-21.

Ex

Other study type (retrospective matched cohort study)

33.

Honore, C., et al., Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study. Eur J Surg Oncol, 2013. 39(3): p. 235-41.

Ex

Other study type (retrospective cohort study)

34.

Hayes and Inc, Intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis resulting from gastric cancer (Structured abstract). Health Technology Assessment Database, 2009(4).

Ex

Unavailable

35.

Goere, D., et al., Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab. BMC Cancer, 2014. 14(148).

Ex

Other study type (study protocol)

36.

Glehen, O., et al., GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer, 2014. 14(183).

Ex

Other study type (study protocol)

37.

Glehen, O., et al., Peritoneal carcinomatosis in digestive cancers: cytoreductive surgery combined with intraperitoneal chemohyperthermia. The experience in Centre Hospitalier et Universitaire Lyon Sud (CHLS). Acta Chir Belg, 2006. 106(3): p. 285-90.

Ex

Other study type (uncontrolled study)

38.

Gill, R.S., et al., Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol, 2011. 104(6): p. 692-8.

Ex

Other study type (narrative review: no quality appraisal, used for reference tracking)

39.

Facchiano E, et al., Laparoscopic hyperthermic intraperitoneal chemotherapy: Indications, aims, and results: A systematic review of the literature. Ann. Surg. Oncol., 2012. 19(9): p. 2946-2950.

Ex

Other intervention (HIPEC by laparoscopy, used for reference tracking: no relevant studies as all included studies had another study design e.g. case studies)

40.

Ding, W.T., et al., Clinical observation on early intraperitoneal hypothermic perfusion chemotherapy in the treatment of stomach carcinoma after operation. Tumor Biol., 2007. 27(7): p. 585-7.

Ex

Untraceable

41.

Coccolini F, et al., Peritoneal carcinomatosis. World J. Gastroenterol., 2013. 19(41): p. 6979-6994.

Ex

Other study type (narrative review: no systematic search or selection)

42.

Coccolini F, et al., Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials. Eur J Surg Oncol, 2014. 40(1): p. 12-26.

In

43.

Chua T.C, et al., Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: A systematic review of morbidity and mortality. Ann. Surg., 2009. 249(6): p. 900-907.

Ex

Other study type (narrative review: no quality appraisal. In addition, all selected studies were non-comparative studies)

44.

Chen, Y., et al., Efficacy of intraperitoneal and intravenous chemotherapy for advanced gastric cancer with peritoneal metastasis. Tumori, 2014. 100(5): p. e180-8.

Ex

Other study type (retrospective controlled cohort study)

45

Bozzetti, F., et al., Locoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol, 2008. 98(4): p. 273-6.

Ex

Other study type (narrative review: no systematic search or selection)